The Real-World Observational Prospective Study of Health Outcomes with Dulaglutide and Liraglutide in Type 2 Diabetes Patients (TROPHIES): Baseline Patient-Reported Outcomes

被引：0
|
作者：
Kristina S. Boye
Hélène Sapin
Luis-Emilio García-Pérez
Myriam Rosilio
Marco Orsini Federici
Elke Heitmann
Heike Jung
Ulrich Aigner
Bruno Guerci
Francesco Giorgino
Kirsi Norrbacka
机构：
[1] Eli Lilly and Company,
[2] Lilly France SAS,undefined
[3] Lilly S.A.,undefined
[4] Eli Lilly and Company,undefined
[5] Lilly Deutschland GmbH,undefined
[6] Versdias GmbH,undefined
[7] University Hospital of Nancy,undefined
[8] University of Bari Aldo Moro,undefined
[9] Eli Lilly and Company,undefined
来源：
Diabetes Therapy | 2020年 / 11卷
关键词：
Dulaglutide; Glucagon-like peptide 1 receptor agonists; Liraglutide; Patient-reported outcomes; Real-world study; Type 2 diabetes patients;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2383 / 2399
页数：16
相关论文
共 50 条
  • [1] The Real-World Observational Prospective Study of Health Outcomes with Dulaglutide and Liraglutide in Type 2 Diabetes Patients (TROPHIES): Baseline Patient-Reported Outcomes
    Boye, Kristina S.
    Sapin, Helene
    Garcia-Perez, Luis-Emilio
    Rosilio, Myriam
    Orsini Federici, Marco
    Heitmann, Elke
    Jung, Heike
    Aigner, Ulrich
    Guerci, Bruno
    Giorgino, Francesco
    Norrbacka, Kirsi
    [J]. DIABETES THERAPY, 2020, 11 (10) : 2383 - 2399
  • [2] THE REAL-WORLD OBSERVATIONAL PROSPECTIVE STUDY OF HEALTH OUTCOMES WITH DULAGLUTIDE AND LIRAGLUTIDE IN TYPE 2 DIABETES PATIENTS (TROPHIES): PATIENT-REPORTED OUTCOMES AT BASELINE
    Boye, K.
    Garcia-Perez, L. E.
    Sapin, H.
    Rosilio, M.
    Federici, Orsini M.
    Heitmann, E.
    Jung, H.
    Gentilella, R.
    Aigner, U.
    Guerci, B.
    Giorgino, F.
    Norrbacka, K.
    [J]. VALUE IN HEALTH, 2019, 22 : S593 - S593
  • [3] The Real-World Observational Prospective Study of Health Outcomes with Dulaglutide and Liraglutide in Type 2 Diabetes Patients (TROPHIES): Final patient-reported outcomes at 24 months
    Boye, Kristina S.
    Lebrec, Jeremie
    Dib, Anne
    Heitmann, Elke
    Federici, Marco Orsini
    Yu, Maria
    Sapin, Helene
    Barrett, Annabel
    Guerci, Bruno
    Giorgino, Francesco
    Fuechtenbusch, Martin
    Garcia-Perez, Luis-Emilio
    [J]. DIABETES OBESITY & METABOLISM, 2023, 25 (12): : 3453 - 3464
  • [4] The Real-World Observational Prospective Study of Health Outcomes with Dulaglutide and Liraglutide in Type 2 Diabetes Patients (TROPHIES) : Final 24-Month Patient-Reported Outcomes
    Fuechtenbusch, Martin
    Guerci, Bruno
    Giorgino, Francesco
    Garcia-Perez, Luis-Emilio
    Heitmann, Elke
    Lebrec, Jeremie
    Barrett, Annabel
    Dib, Anne
    Federici, Marco Orsini
    Boye, Kristina
    [J]. DIABETES, 2022, 71
  • [5] THE REAL-WORLD OBSERVATIONAL PROSPECTIVE STUDY OF HEALTH OUTCOMES WITH DULAGLUTIDE & LIRAGLUTIDE IN TYPE 2 DIABETES PATIENTS (TROPHIES): PATIENT REPORTED OUTCOMES AT 12-MONTHS
    Boye, K.
    Lebrec, J.
    Sapin, H.
    Guerci, B.
    Giorgino, F.
    Fuechtenbusch, M.
    Heitmann, E.
    Federici, Orsini M.
    Dib, A.
    Garcia-Perez, L. E.
    [J]. VALUE IN HEALTH, 2022, 25 (01) : S242 - S242
  • [6] The Real-World Observational Prospective Study of Health Outcomes with Dulaglutide and Liraglutide in Type 2 Diabetes Patients (TROPHIES): Design and Baseline Characteristics
    Luis-Emilio García-Pérez
    Kristina S. Boye
    Myriam Rosilio
    Heike Jung
    Elke Heitmann
    Kirsi Norrbacka
    Marco Orsini Federici
    Raffaella Gentilella
    Bruno Guerci
    Francesco Giorgino
    Ulrich Aigner
    Hélène Sapin
    [J]. Diabetes Therapy, 2021, 12 : 1929 - 1946
  • [7] THE REAL-WORLD OBSERVATIONAL PROSPECTIVE STUDY OF HEALTH OUTCOMES WITH DULAGLUTIDE & LIRAGLUTIDE IN TYPE 2 DIABETES PATIENTS (TROPHIES): DESIGN AND BASELINE CHARACTERISTICS
    Garcia-Perez, L. E.
    Sapin, H.
    Norrbacka, K.
    Guerci, B.
    Giorgino, F.
    Aigner, U.
    Federici, Orsini M.
    Gentilella, R.
    Heitmann, E.
    Jung, H.
    Rosilio, M.
    Boye, K.
    [J]. VALUE IN HEALTH, 2019, 22 : S593 - S593
  • [8] The Real-World Observational Prospective Study of Health Outcomes with Dulaglutide and Liraglutide in Type 2 Diabetes Patients (TROPHIES): Design and Baseline Characteristics
    Garcia-Perez, Luis-Emilio
    Boye, Kristina S.
    Rosilio, Myriam
    Jung, Heike
    Heitmann, Elke
    Norrbacka, Kirsi
    Federici, Marco Orsini
    Gentilella, Raffaella
    Guerci, Bruno
    Giorgino, Francesco
    Aigner, Ulrich
    Sapin, Helene
    [J]. DIABETES THERAPY, 2021, 12 (07) : 1929 - 1946
  • [9] THE REAL-WORLD OBSERVATIONAL PROSPECTIVE STUDY OF HEALTH OUTCOMES WITH DULAGLUTIDE AND LIRAGLUTIDE IN TYPE 2 DIABETES PATIENTS (TROPHIES): COUNTRY-SPECIFIC BASELINE CHARACTERISTICS
    Sapin, H.
    Garcia-Perez, L. E.
    Norrbacka, K.
    Giorgino, F.
    Guerci, B.
    Aigner, U.
    Federici, Orsini M.
    Gentilella, R.
    Heitmann, E.
    Jung, H.
    Rosilio, M.
    Boye, K.
    [J]. VALUE IN HEALTH, 2019, 22 : S588 - S588
  • [10] The Real-World Observational Prospective Study of Health Outcomes with Dulaglutide and Liraglutide in Type 2 Diabetes Patients (TROPHIES): Twelve-Month Data Analysis
    Guerci, Bruno
    Giorgino, Francesco
    Garcia, Luis-Emilio
    Boye, Kristina
    Norrbacka, Kirsi
    Sapin, Helene
    Heitmann, Elke
    Lebrec, Jeremie
    Dib, Anne
    Federici, Marco O. Orsini
    [J]. DIABETES, 2021, 70
12345